Research SummaryKey Findings

What research findings exist regarding Oxytocin Acetate in uterine contractions and postpartum hemorrhage prevention?

Earlier initiated study showed less intraoperative blood loss and hemoglobin decrease in infusion group, supporting study on optimal obstetric administration timing. Additional research reports: less severe postpartum hemorrhage, transfusion, and high-dependency unit admission in intravenous group.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
i

Currently, 3 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

Comparison of study design and results

Results from different populations, species, materials, or follow-up times cannot be directly combined. The table below is a comparative summary of published data, not new experimental data.

LiteratureStudy subjects and designObservation and discoveryScope of Explanation
2026 · PMID 4216572868 women with full-term elective cesarean; open randomized infusion timing comparison.Earlier initiated study showed less intraoperative blood loss and hemoglobin decrease in infusion group, supporting study on optimal obstetric administration timing.Small-sample single-center open trial, specific clinical protocol; cannot be converted to personal use or site research product use.
2018 · PMID 301813381,075 women planning vaginal delivery were randomly assigned; 1,035 included in analysis; comparison by routeSevere postpartum hemorrhage in the intravenous group, transfusion, and ICU admission are rare.Major ≥500mL bleeding endpoint did not reach significant intergroup difference; historical study in 2018, does not mean all endpoints improved.
2013 · PMID 24130463A cluster randomized trial including 54 community health personnel; 1,586 postpartum women.The incidence of postpartum hemorrhage in the prophylactic clinical oxytocin intervention group is lower than in the control group not given this preventive intervention.Non-blinded, unequal group numbers, and specific service systems; does not support research raw materials for labor, nor is it a self-use recommendation.

References

Human Study2026REF. 01

What findings are there on the timing of infusion in scheduled cesarean sections?

Research Findings

Earlier initiated study showed less intraoperative blood loss and hemoglobin decrease in infusion group, supporting study on optimal obstetric administration timing.[1] ↗

Study Design

68 women with full-term elective cesarean; open randomized infusion timing comparison.

Scope & Limitations

Small-sample single-center open trial, specific clinical protocol; cannot be converted to personal use or site research product use.

View the Article Title and Full Citation+

Prophylactic oxytocin infusion for reducing blood loss during elective caesarean delivery: A randomised controlled trial.

Govindan P, Sharma J, N S K, Kundra P, Maurya DK, Keepanasseril A

The Indian Journal of Medical Research · Volume Issue Year 2026
First published 2026-04-01 · PMID 42165728
DOI 10.25259/IJMR_2952_2025

Human Study2018 · Historical basic researchREF. 02

Are the endpoints of postpartum hemorrhage consistent across different routes?

Research Findings

Severe postpartum hemorrhage in the intravenous group, transfusion, and ICU admission are rare.[2] ↗

Study Design

1,075 women planning vaginal delivery were randomly assigned; 1,035 included in analysis; comparison by route

Scope & Limitations

Major ≥500mL bleeding endpoint did not reach significant intergroup difference; historical study in 2018, does not mean all endpoints improved.

View the Article Title and Full Citation+

Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial.

Adnan N, Conlan-Trant R, McCormick C, Boland F, Murphy DJ

BMJ (Clinical Research Ed.) · Volume and Year 2018
First published 2018-09-04 · PMID 30181338
DOI 10.1136/bmj.k3546

Human Study2013 · Historical basic researchREF. 03

What are the results of post-partum hemorrhage prevention in cluster randomized trials?

Research Findings

The incidence of postpartum hemorrhage in the prophylactic clinical oxytocin intervention group is lower than in the control group not given this preventive intervention.[3] ↗

Study Design

A cluster randomized trial including 54 community health personnel; 1,586 postpartum women.

Scope & Limitations

Non-blinded, unequal group numbers, and specific service systems; does not support research raw materials for labor, nor is it a self-use recommendation.

View the Article Title and Full Citation+

Effect on postpartum hemorrhage of prophylactic oxytocin (10 IU) by injection by community health officers in Ghana: a community-based, cluster-randomized trial.

Stanton CK, Newton S, Mullany LC, Cofie P, Tawiah Agyemang C, Adiibokah E, Amenga-Etego S, Darcy N, Khan S, Armbruster D, Gyapong J, Owusu-Agyei S

PLoS Medicine · Volume, issue, year 2013
First published on 2013-10-01 · PMID 24130463
DOI 10.1371/journal.pmed.1001524

Common issues and corresponding evidence

What research findings exist regarding Oxytocin Acetate in uterine contractions and postpartum hemorrhage prevention?+

Earlier initiated study showed less intraoperative blood loss and hemoglobin decrease in infusion group, supporting study on optimal obstetric administration timing. Additional research reports: less severe postpartum hemorrhage, transfusion, and high-dependency unit admission in intravenous group.[1] ↗ [2] ↗

In postpartum hemorrhage studies, were all endpoints improved?+

No. In pathway comparison trials, minor endpoints such as severe postpartum hemorrhage and transfusion were better, but the primary ≥500mL bleeding endpoint did not show significant intergroup differences. Different endpoints should be stated separately, and clinical research does not verify the research materials on this site.[2] ↗

Oxytocin Acetate—these conclusions apply to which study populations?+

68 women with full-term elective cesarean; open randomized infusion timing comparison; 1,075 women planning vaginal delivery were randomly assigned, 1,035 included in analysis; route comparison; a cluster randomized trial in Ghana with 54 community health workers; 1,586 mothers. Small sample single-center open trial, specific clinical protocol; cannot be converted for personal use or commercial research purposes.[1] ↗ [2] ↗ [3] ↗

Oxytocin Acetate

Return to catalog specifications and batch file verification entry.

↗